GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Abbott Laboratories (BSP:ABTT34) » Definitions » Change In Receivables

Abbott Laboratories (BSP:ABTT34) Change In Receivables : R$-4,539 Mil (TTM As of Mar. 2025)


View and export this data going back to 2012. Start your Free Trial

What is Abbott Laboratories Change In Receivables?

Abbott Laboratories's change in receivables for the quarter that ended in Mar. 2025 was R$-1,509 Mil. It means Abbott Laboratories's Accounts Receivable increased by R$1,509 Mil from Dec. 2024 to Mar. 2025 .

Abbott Laboratories's change in receivables for the fiscal year that ended in Dec. 2024 was R$-4,216 Mil. It means Abbott Laboratories's Accounts Receivable increased by R$4,216 Mil from Dec. 2023 to Dec. 2024 .

Abbott Laboratories's Accounts Receivable for the quarter that ended in Mar. 2025 was R$42,190 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Abbott Laboratories's Days Sales Outstanding for the three months ended in Mar. 2025 was 64.55.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Abbott Laboratories's liquidation value for the three months ended in Mar. 2025 was R$-96,306 Mil.


Abbott Laboratories Change In Receivables Historical Data

The historical data trend for Abbott Laboratories's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott Laboratories Change In Receivables Chart

Abbott Laboratories Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4,753.70 -2,165.83 -356.69 -1,744.33 -4,215.79

Abbott Laboratories Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -751.95 -1,750.48 -315.66 -963.96 -1,508.62

Abbott Laboratories Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was R$-4,539 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abbott Laboratories  (BSP:ABTT34) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Abbott Laboratories's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=42189.599/59642.4*91
=64.55

2. In Ben Graham's calculation of liquidation value, Abbott Laboratories's accounts receivable are only considered to be worth 75% of book value:

Abbott Laboratories's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=39408.436-186470.31+0.75 * 42189.599+0.5 * 38228.026
=-96,306

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abbott Laboratories Change In Receivables Related Terms

Thank you for viewing the detailed overview of Abbott Laboratories's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Abbott Laboratories Business Description

Address
100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

Abbott Laboratories Headlines

No Headlines